CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
April 2023—BioGx announced accelerated adoption of its high-performance Sample-Ready PCR assay for the detection of Candida auris. A complete PCR mix is provided in a single lyophilized tube format to be validated by laboratories on a variety of real-time PCR instruments, including the BD Max, Thermo Fisher QuantStudio, Bio-Rad CFX Touch, and BioGx Pixl platform. The company says its assay has been successfully validated and implemented by public health laboratories and hospitals in several states.
A study published in Annals of Internal Medicine pointed to a rising number of cases of Candida auris in recent years, with a large increase in 2021 (Lyman M, et al. Ann Intern Med. Published online March 21, 2023. doi.org/10.7326/M22-3469).
BioGx, 205-250-8055